Peripheral Artery Disease (PAD)

Clinical Trial Finder

Many patients with peripheral arterial disease are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Efficacy and Safety of Rivaroxaban in Reducing the Risk of Major Thrombotic Vascular Events in Subjects With Symptomatic Peripheral Artery Disease Undergoing Peripheral Revascularization Procedures of the Lower Extremities

Condition:   Peripheral Artery Disease
Interventions:   Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Rivaroxaban-Placebo
Sponsors:   Bayer;   Janssen Research & Development, LLC;   Colorado Prevention Center
Active, not recruiting

Exercise and Weight Loss in PAD

Condition:   Peripheral Arterial Disease
Interventions:   Other: Exercise;   Other: Weight Loss
Sponsor:   VA Office of Research and Development
Recruiting

Short vs Long Duration Dual Antiplatelet Therapy in Patients Undergoing Lower Extremity Endovascular Revascularization

Conditions:   Peripheral Arterial Disease;   Endovascular Procedures
Interventions:   Drug: Aspirin;   Drug: Clopidogrel
Sponsor:   University Hospitals Cleveland Medical Center
Withdrawn

Standard Versus PICO Dressings in Lower-Extremity Bypass Patients

Conditions:   Of Bypass Graft of the Extremities;   Peripheral Arterial Disease;   Vascular Diseases;   Cardiovascular Diseases
Interventions:   Device: PICO Single-Use Negative Pressure Dressings;   Other: Sterile Gauze Dressings
Sponsors:   Boston Medical Center;   Smith & Nephew, Inc.
Recruiting

Outcomes of Endovascular Treatment of Superficial Femoral Artery In-stent Restenosis

Condition:   Peripheral Arterial Disease
Intervention:   Procedure: PTA
Sponsor:   Assiut University
Not yet recruiting

EverFlex Post Approval Study

Conditions:   Peripheral Arterial Disease;   Lower Extremity Arterial Disease
Intervention:   Device: EverFlex™ Self-Expanding Peripheral Stent System
Sponsor:   Medtronic Endovascular
Completed

Safety Study of Gene Therapy in Treating Lower Leg Ischemia

Condition:   Critical Limb Ischemia
Interventions:   Biological: VM202 2mg;   Biological: VM202 4mg;   Biological: VM202 8mg;   Biological: VM202 16mg
Sponsor:   Helixmith Co., Ltd.
Completed

Evaluation of the Tissue Genesis® Icellator Cell Isolation System™ to Treat Critical Limb Ischemia

Condition:   Critical Limb Ischemia
Intervention:   Device: TGI SVF material via intramuscular injection
Sponsors:   Tissue Genesis, LLC;   U.S. Army Medical Research and Development Command
Active, not recruiting

Cohort Study of Patients Treated for Peripheral Arterial Occlusive Disease

Condition:   Peripheral Arterial Obstructive Disease
Intervention:  
Sponsor:   Groupe Hospitalier Paris Saint Joseph
Not yet recruiting

Study to Gain Insights in Treatment Patterns and Outcomes in Patients With Atherosclerosis Prescribed to Xarelto in Combination With Acetylsalicylic Acid

Condition:   Atherosclerosis
Interventions:   Drug: Rivaroxaban (BAY59-7939, Xarelto);   Drug: Acetylsalicylic acid
Sponsors:   Bayer;   Janssen, LP
Recruiting

Comparing OutcomeS of Through Knee and Above Knee Amputation

Condition:   Through Knee Amputation
Interventions:   Other: Qualitative interviews and focus groups;   Other: Biomechanical gait analysis and questionnaires
Sponsors:   Hull and East Yorkshire Hospitals NHS Trust;   University of Hull
Recruiting

Safety and Efficacy of the Noxsano Wound Care Bandage

Conditions:   Wound Heal;   Peripheral Artery Disease;   Ulcer, Leg;   Ulcer Foot;   Diabetic Foot Ulcer;   Arterial Insufficiency
Interventions:   Device: Noxsano Bandage (Healthy Volunteers);   Device: Noxsano Bandage (Wound Care)
Sponsors:   OhioHealth;   Noxsano, Inc.
Recruiting

Bard LifeStent and Lutonix DCB for Treatment of Long Lesions in Femoropopliteal Arteries

Condition:   Peripheral Artery Disease
Intervention:   Device: Lutonix Drug Coated Balloon
Sponsor:   C. R. Bard
Completed